Quetiapine Fumarate

CAS No. 111974-72-2

Quetiapine Fumarate( ICI 204636 )

Catalog No. M10430 CAS No. 111974-72-2

Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
200MG 27 In Stock
500MG 41 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Quetiapine Fumarate
  • Note
    Research use only, not for human use.
  • Brief Description
    Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression.
  • Description
    Quetiapine Fumarate is an atypical antipsychotic used in the treatment of schizophrenia, bipolar I mania, bipolar II depression, bipolar I depression.(In Vitro):Quetiapine (<100?μM; 24?hours) has no significant effect on cell viabilities.Quetiapine (10?μM) inhibits NO release, which increased by LPS (0.1-100 ng/mL) in concentration-dependent manner.Quetiapine (10?μM) also inhibits TNF-α synthesis.(In Vivo):Quetiapine (10?mg/kg/day; ingested) can alleviate the recruitment and activation of microglia and promote myelin repair in Cuprizone (CPZ)-induced chronic mouse model of demyelination.
  • In Vitro
    Quetiapine (<100?μM; 24?hours) has no significant effect on cell viabilities.Quetiapine (10?μM) inhibits NO release, which increased by LPS (0.1-100 ng/mL) in concentration-dependent manner. Quetiapine (10?μM) also inhibits TNF-α synthesis. Cell Viability Assay Cell Line:N9 microglial cells Concentration:0, 0.1, 1, 10, 50, and 100?μM Incubation Time:24?hours Result:Had no significant effect on cell viabilities at various concentrations under 100?μM, in which significant toxicity could be observed. RT-PCR Cell Line:N9 microglial cells Concentration:10?μM Incubation Time:24?hours Result:Dramatically inhibited TNF-α synthesis.
  • In Vivo
    Quetiapine (10?mg/kg/day; ingested) can alleviate the recruitment and activation of microglia and promote myelin repair in Cuprizone (CPZ)-induced chronic mouse model of demyelination. Animal Model:C57BL/6 mice Dosage:10?mg/kg/day Administration:Ingested Result:Significantly increased in optical density of myelin basic protein (MBP) staining compared to Veh group.
  • Synonyms
    ICI 204636
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    HT| Adrenergic Receptor| Dopamine
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    111974-72-2
  • Formula Weight
    883.09
  • Molecular Formula
    C46H54N6O8S2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 36 mg/mL (40.76 mM)
  • SMILES
    C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C1CN(CCN1CCOCCO)C2=NC3=CC=CC=C3SC4=CC=CC=C42.C(=C/C(=O)O)\C(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nemeroff CB, et al. J Clin Psychiatry, 2002, 63 Suppl 13, 5-1
molnova catalog
related products
  • 4i

    4i is a 5-HT3 receptor antagonist,It modulates the serotonergic system.

  • Vortioxetine

    Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively.

  • Almotriptan

    Almotriptan is a 5-HT1B/1D-receptor agonist used to treat migraine.Almotriptan is a triptan drug for treatment of migraine headaches.